Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.
作者信息
Desai Seemal R, Frieden Ilona J, Gelfand Joel M, High Whitney, Kavanaugh Arthur, Marghoob Ashfaq A, Ozog David M, Rosen Ted, Stein Gold Linda, Strober Bruce, Swanson Neil, Martin George
机构信息
University of Texas Southwestern Medical Center Dallas, TX.
University of California, San Francisco San Francisco, CA.
出版信息
J Clin Aesthet Dermatol. 2015 Sep;8(9 Suppl):S4-S26.
Abstract
摘要
相似文献
1
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.
J Clin Aesthet Dermatol. 2015 Sep;8(9 Suppl):S4-S26.
2
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting.
J Clin Aesthet Dermatol. 2014 Jul;7(7 Suppl SC2S5-S22):S5-S22.
3
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.
J Clin Aesthet Dermatol. 2017 Sep;10(9 Suppl):S8-S41. Epub 2017 Sep 1.
4
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.
J Clin Aesthet Dermatol. 2013 Sep;6(9 Suppl):S2-S20.
5
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.
J Clin Aesthet Dermatol. 2016 Sep;9(9 Suppl 1):S5-S29. Epub 2016 Sep 1.
6
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting.
J Rheumatol. 2023 Nov;50(Suppl 2):61-65. doi: 10.3899/jrheum.2023-0534. Epub 2023 Aug 1.
7
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting.
J Rheumatol. 2022 Jun;49(6 Suppl 1):57-63. doi: 10.3899/jrheum.211336. Epub 2022 Apr 1.
8
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
J Rheumatol. 2014 Jun;41(6):1194-6. doi: 10.3899/jrheum.140168.
9
Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK.
Br J Dermatol. 2012 Feb;166(2):252-60. doi: 10.1111/j.1365-2133.2011.10767.x.
10
Report from the 67th annual meeting of the American Academy of Dermatology.
Br J Dermatol. 2010 Jan;162(1):12-21. doi: 10.1111/j.1365-2133.2009.09395.x. Epub 2009 Jul 31.
引用本文的文献
1
Autologous full-thickness skin graft for treating squamous carcinoma in a patient with psoriasis.
Medicine (Baltimore). 2020 Sep 25;99(39):e22252. doi: 10.1097/MD.0000000000022252.
本文引用的文献
1
Apremilast for the treatment of psoriasis.
Expert Opin Pharmacother. 2015;16(13):2083-94. doi: 10.1517/14656566.2015.1076794. Epub 2015 Aug 4.
2
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
J Am Acad Dermatol. 2015 Jul;73(1):37-49. doi: 10.1016/j.jaad.2015.03.049.
3
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
J Am Acad Dermatol. 2015 Jun;72(6):1021-6.e8. doi: 10.1016/j.jaad.2015.03.021.
4
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
JAMA Dermatol. 2015 Sep;151(9):961-9. doi: 10.1001/jamadermatol.2015.0718.
5
General psychiatric symptoms, quality of sleep, and coping strategies in patients with psoriasis vulgaris.
Int J Dermatol. 2016 Jan;55(1):60-4. doi: 10.1111/ijd.12649. Epub 2015 May 6.
6
Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice.
J Dermatolog Treat. 2015;26(6):502-6. doi: 10.3109/09546634.2015.1034070. Epub 2015 Apr 17.
7
Restless legs syndrome in psoriasis: an unexpected comorbidity.
Eur J Dermatol. 2015 May-Jun;25(3):255-60. doi: 10.1684/ejd.2015.2525.
8
Association between depression and risk of atrial fibrillation and stroke in patients with psoriasis: a Danish nationwide cohort study.
Br J Dermatol. 2015 Aug;173(2):471-9. doi: 10.1111/bjd.13778. Epub 2015 Jun 11.
9
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis.
Br J Dermatol. 2015 Sep;173(3):767-76. doi: 10.1111/bjd.13745. Epub 2015 Jun 19.
10
Tofacitinib for the treatment of moderate-to-severe psoriasis.
Expert Rev Clin Immunol. 2015 Apr;11(4):443-55. doi: 10.1586/1744666X.2015.1013534. Epub 2015 Feb 10.
Zotero 插件